AGC Pharma Chemicals is pleased to announce our participation in CPHI Japan 2025, one of Asia’s leading pharmaceutical trade shows, taking place from April 9th to 11th at Tokyo Big Sight in Tokyo, Japan.
You’ll find AGC Pharma Chemicals at booth 5M-30, where our team will showcase our capabilities as a global Contract Development and Manufacturing Organization (CDMO) for small molecule APIs and Intermediates, with a strong presence in Barcelona and Japan.
This key industry event brings together professionals from across the pharmaceutical value chain to explore the latest innovations, technologies, and services shaping the future of pharma in Japan and beyond. With over 730 exhibitors and more than 26,000 attendee visits expected, CPHI Japan offers a unique opportunity to engage with potential partners, clients, and collaborators.
We look forward to discussing how we support pharmaceutical projects from early development through to commercial manufacturing, offering advanced technologies, flexible scale-up, and high-containment solutions for High Potency APIs (HPAPIs).
On April 10th, we will also host an exhibitor presentation in room 5B, where engineers from our Yokohama Technical Center will share insights into the latest innovations in pharmaceutical process development and manufacturing. This is a great opportunity to learn more about how AGC is driving innovation in the CDMO space.
Let’s connect at CPHI Japan 2025
In addition to the AGC Pharma Chemicals team, we’ll be joined by colleagues from our AGC Biologics division to assist visitors interested in biopharmaceutical services, offering a comprehensive view of AGC’s end-to-end capabilities.
We invite you to visit us at booth 5M-30 or schedule a meeting with our team to discuss your development and manufacturing needs. Whether you’re looking for small molecule API expertise or biologics support, AGC Pharma Chemicals delivers integrated, global solutions tailored to your project.
